Released May 12, 2021, after the close
10-Q filed May 14, 2021, 44 days after period end · 0001558370-21-007255
Q1 2021 · 10-Q
Revenue$0.00$0.00 no prior Q1 2020 on fileno prior Q4 2020 on file
Net Income-$3.48M-$3.48M N/M vs Q1 2020N/M vs Q4 2020
EPS Diluted-$0.50-$0.50 N/M vs Q1 2020no prior Q4 2020 on file
Operating Income-$4,305,000N/M
Operating Cash Flow-$3,566,000N/M
Free Cash Flowderived-$3,644,000N/M
What the release said
The release
Same quarter
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $0.00 | — | $0.00 | $0.00 |
| Net Income | -$3.48M | -$1.22M | -$1.84M | -$1.35M |
| EPS Diluted | -$0.50 | -$1.48 | -$2.77 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR